Equity Overview
Price & Market Data
Price: $0.409
Daily Change: $0.00 / 0.00%
Daily Range: $0.38 - $0.409
Market Cap: $6,951,732
Daily Volume: 791
Performance Metrics
1 Week: -4.79%
1 Month: 13.72%
3 Months: 42.80%
6 Months: 14.69%
1 Year: -12.89%
YTD: -0.15%
Details
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid addiction and alcoholism. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.